Reata Pharma
(RETA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 8,242 | 7,833 | 7,770 | 8,451 | 5,175 |
| Gross Profit | 8,242 | 7,833 | 7,770 | 8,451 | 5,175 |
| Operating Expenses | 46,820 | 41,492 | 36,322 | 33,373 | 34,735 |
| Operating Income | -38,578 | -33,659 | -28,552 | -24,922 | -29,560 |
| Interest Expense | 0 | 0 | 0 | 0 | 2,360 |
| Other Income | -1,078 | -701 | -600 | -649 | 1,094 |
| Pre-tax Income | -39,656 | -34,360 | -29,152 | -25,571 | -30,826 |
| Income Tax | 38 | 20 | 2 | 11 | 9 |
| Net Income Continuous | -39,694 | -34,380 | -29,154 | -25,582 | -30,835 |
| Net Income | $-39,694 | $-34,380 | $-29,154 | $-25,582 | $-30,835 |
| EPS Basic Total Ops | -1.32 | -1.14 | -0.98 | -0.92 | -1.07 |
| EPS Basic Continuous Ops | -1.32 | -1.14 | -0.98 | -0.91 | -1.07 |
| EPS Diluted Total Ops | -1.32 | -1.14 | -0.98 | -0.91 | -1.07 |
| EPS Diluted Continuous Ops | -1.32 | -1.14 | -0.98 | -0.91 | -1.07 |
| EBITDA(a) | $-37,981 | $-33,089 | $-28,043 | $-24,463 | $-29,116 |